Does Fortovase Capsule Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- PROTEASE INHIBITORS/ORAL MIDAZOLAM; TRIAZOLAM
- SELECTED CYP3A4 INHIBITORS/PIMOZIDE
- PROTEASE INHIBITORS/ERGOT ALKALOIDS
- SELECTED CYP3A4 SUBSTRATES/RIFAMPIN
- PROTEASE INHIBITORS; COBICISTAT/ASTEMIZOLE; TERFENADINE
- SELECTED CYP3A4 SUBSTRATES/ST. JOHN'S WORT
- SAQUINAVIR/SELECTED QT PROLONGING AGENTS
- PROTEASE INHIBITORS/APALUTAMIDE
- SENSITIVE CYP3A4 SUBSTRATES THAT PROLONG QT/ORAL LEFAMULIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GEPIRONE
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/CISAPRIDE
- STR 3A4 INHIB;ATAZAN;DARUN/COLCHICINE (FOR CARDIOPROTECTION)
- STRONG CYP3A4 INHIBIT THAT PROLONG QT/PIMAVANSERIN (> 10 MG)
- STRONG CYP3A4 INHIBITORS/MAVACAMTEN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/PACRITINIB
- STR CYP3A4 INHIBITORS THAT PROLONG QT/PANOBINOSTAT (> 10 MG)
- STRONG CYP3A4 INHIBITORS/DARIDOREXANT
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/LEVOKETOCONAZOLE
- SELECTED STRONG CYP3A4 INHIBITORS/CONIVAPTAN
- STRONG CYP3A4 INHIBITORS/FINERENONE
- STRONG CYP3A4 INHIBITORS/VOCLOSPORIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/RANOLAZINE
- STRONG AND MODERATE CYP3A4 INHIBITORS/LONAFARNIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/IVABRADINE
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (>10.5 MG)
- STRONG CYP3A4 INHIBITORS/UBROGEPANT
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR;DARUNAVIR/LERCANIDIPINE
- SAQUINAVIR/LIDOCAINE
- STRONG & MOD 3A4 INHIB THAT PROLONG QT/CILOSTAZOL (> 50 MG)
- STRONG CYP3A4 INHIBITORS/DAPAGLIFLOZIN-SAXAGLIPTIN-METFORMIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
- STRONG CYP3A4 INHIBITORS/VALBENAZINE (> 40 MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
- OATP1B1-3 INHIBITORS/ELBASVIR-GRAZOPREVIR
- SELECTED STRONG CYP3A4 INHIBITORS/ISAVUCONAZONIUM
- STRONG CYP3A4 INHIBITORS/NALOXEGOL
- QT PROLONGING AGENTS/ANAGRELIDE
- SAQUINAVIR/DOFETILIDE
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/AVANAFIL
- 3A4INHIB/DAPOXETINE;LEVOMILNACIPRAN(>80MG);VILAZODONE(>20MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
- STRONG CYP3A4 INHIBITORS/SLT HIGH STRENGTH ANTIMUSCARINICS
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/DOMPERIDONE
- SELECTED PROTEASE INHIBITORS/ATORVASTATIN (>20 MG)
- SAQUINAVIR/TRAZODONE
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/TICAGRELOR
- PROTEASE INHIBITORS; COBICISTAT/LURASIDONE
- HIV PROTEASE INHIBITORS; COBICISTAT/SILDENAFIL (FOR PAH)
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN (>2.5 MG)
- STRONG CYP3A4 INHIBITORS; DARUNAVIR/DRONEDARONE
- HIV PROTEASE INHIBITORS; COBICISTAT/RIVAROXABAN
- STRONG CYP3A4 INHIBITORS/TOLVAPTAN
- SAQUINAVIR/SELECTED ANTIARRHYTHMICS
- PROTEASE INHIBITORS/ALFUZOSIN;SILODOSIN;TAMSULOSIN
- SELECTED PROTEASE INHIBITORS/VARDENAFIL (> 2.5 MG)
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/EPLERENONE
- STRONG CYP3A4 INHIBITORS/IRINOTECAN
- SELECTED PROTEASE INHIBITORS; COBICISTAT/ELETRIPTAN
- SELECTED CYP3A4 INHIBITORS/LOVASTATIN; SIMVASTATIN
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED PROTEASE INHIBITORS/ALPRAZOLAM
- SELECTED PROTEASE INHIBITORS/NEVIRAPINE
- SELECTED PROTEASE INHIBITORS/RIFABUTIN; RIFAPENTINE
- PROTEASE INHIBITORS/CARBAMAZEPINE
- FOSAMPRENAVIR; SAQUINAVIR/EFAVIRENZ
- SAQUINAVIR/LOPERAMIDE
- SAQUINAVIR/GARLIC
- SAQUINAVIR/QT PROLONGING AGENTS
- SAQUINAVIR/DAPSONE
- PROTEASE INHIBITORS/ENZALUTAMIDE
- SEL SENSITIVE 3A4 SUBSTRATES THAT PROLONG QT/ADAGRASIB
- ANTI-RETROVIRALS/ATIDARSAGENE AUTOTEMCEL
- ANTI-RETROVIRALS/LOVOTIBEGLOGENE AUTOTEMCEL
- STRONG AND MODERATE CYP3A4 INHIBITORS/NIROGACESTAT
- STRONG CYP3A4 INHIBITORS/CAPIVASERTIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/REPOTRECTINIB
- STRONG CYP3A4 OR MODERATE CYP2C9 INHIBITORS/ERDAFITINIB
- STRONG CYP3A4 INHIBITORS/REBOXETINE
- SELECTED CYP3A4 INHIBITORS/MEPERIDINE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/QUIZARTINIB
- STRONG CYP3A4 INHIBITORS/PALOVAROTENE
- STRONG CYP3A4 INHIBITORS/TRETINOIN
- STRONG CYP3A4 INHIBITORS/LENIOLISIB
- STRONG CYP3A4 INHIBITORS/OMAVELOXOLONE
- STRONG CYP3A4 INHIBITORS/SPARSENTAN
- HIV PROTEASE INHIBITORS; COBICISTAT/APIXABAN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ELACESTRANT
- STRONG CYP3A4 INHIBITORS/PIRTOBRUTINIB
- SELECT PROTEASE INHIBITORS; COBICISTAT/TADALAFIL (BPH)
- STRONG CYP3A4 INHIBITORS/PEXIDARTINIB
- DUAL STRONG CYP3A4 & P-GP INHIBITORS/FUTIBATINIB
- ANTI-RETROVIRALS/ELIVALDOGENE AUTOTEMCEL
- ANTI-RETROVIRALS; HYDROXYUREA/BETIBEGLOGENE AUTOTEMCEL
- STRONG CYP3A4 INHIBITORS/MITAPIVAT
- STR 3A4 INHIB PROL QT/TOLTERODINE (>1 MG IR OR >2 MG ER)
- STRONG CYP3A4 INHIBITORS/RIVOCERANIB
- STRONG CYP3A4 INHIBITORS/UPADACITINIB (>=30 MG)
- STRONG CYP3A4 INHIBITORS/RUPATADINE
- STRONG & MODERATE 3A4 INHIB THAT PROLONG QT/ENCORAFENIB
- STRONG CYP3A4 INHIBITORS/SURUFATINIB
- STRONG CYP3A4 INHIBITORS/AVACOPAN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/RIBOCICLIB
- STRONG CYP3A4 INHIBITORS/ATOGEPANT
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/MOBOCERTINIB
- STRONG 3A4 INHIBITORS THAT PROLONG QT/BEDAQUILINE;DELAMANID
- STRONG & MODERATE 3A4 INHIBITOR THAT PROLONG QT/FEXINIDAZOLE
- STRONG CYP3A4 INHIB THAT PROLONG QT/ARTEMETHER;LUMEFANTRINE
- OATP1B1-3 INHIBITORS/BRINCIDOFOVIR
- STRONG AND MODERATE CYP3A4 INHIBITORS/INFIGRATINIB
- STRONG CYP3A4 INHIBIT THAT PROLONG QT/PIMAVANSERIN (<=10 MG)
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GLASDEGIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/BOSUTINIB
- STRONG CYP3A4 INHIBITORS/VINFLUNINE
- STRONG CYP3A4 INHIBITORS/VINCRISTINE
- STRONG CYP3A4 INHIBITORS/VINBLASTINE
- STRONG CYP3A4 INHIBITORS/TOFACITINIB
- STRONG CYP3A4 INHIBITORS/SONIDEGIB
- STRONG CYP3A4 INHIBITORS/RUXOLITINIB
- STRONG CYP3A4 INHIBITORS/PONATINIB
- STRONG CYP3A4 INHIBITORS/PALBOCICLIB
- STRONG CYP3A4 INHIBITORS/PACLITAXEL
- STRONG CYP3A4 INHIBITORS/OLAPARIB
- STRONG CYP3A4 INHIBITORS/IXABEPILONE
- STRONG CYP3A4 INHIBITORS/IDELALISIB
- STRONG CYP3A4 INHIBITORS/ERLOTINIB
- STRONG CYP3A4 INHIBITORS/DOXORUBICIN
- STRONG CYP3A4 INHIBITORS/DOCETAXEL
- STRONG CYP3A4 INHIBITORS/DABRAFENIB
- STRONG CYP3A4 INHIBITORS/COBIMETINIB
- STRONG CYP3A4 INHIBITORS/CABOZANTINIB
- STRONG CYP3A4 INHIBITORS/CABAZITAXEL
- STRONG CYP3A4 INHIBITORS/AXITINIB
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/SUVOREXANT
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/IVOSIDENIB
- DUAL STRONG CYP3A4 AND P-GP INHIBITORS/PRALSETINIB
- STRONG CYP3A4 INHIBITORS/PLITIDEPSIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/VEMURAFENIB
- STRONG CYP3A4 INHIBITORS/LURBINECTEDIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/QUETIAPINE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/SELPERCATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/OSILODROSTAT
- STRONG CYP3A4 INHIBITORS/RIMEGEPANT
- STRONG CYP3A4 INHIBITORS/NIMODIPINE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ROMIDEPSIN
- STRONG CYP3A4 INHIBITORS/TAZEMETOSTAT
- STRONG CYP3A4 INHIBITORS/AVAPRITINIB
- SELECTED CYP3A4 INHIBITORS/SALMETEROL COMBINATIONS
- STRONG AND MODERATE CYP3A4 INHIBITORS/LEMBOREXANT
- STRONG CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
- STRONG CYP3A4 INHIBITORS/NALDEMEDINE
- STRONG CYP3A4 INHIBITORS/ISTRADEFYLLINE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ENTRECTINIB
- STRONG CYP3A4 INHIBITORS/FEDRATINIB
- STRONG CYP3A4 INHIBITORS/PEXIDARTINIB (200 MG)
- SAQUINAVIR/SELECTED ANTINEOPLASTICS THAT PROLONG QT
- SELECTED PROTEASE INHIBITORS; COBICISTAT/CLOPIDOGREL
- STRONG CYP3A4 INHIBITORS/LAROTRECTINIB
- STRONG CYP3A4 INHIBITORS/LORLATINIB
- STRONG CYP3A4 INHIBITORS/DUVELISIB
- STRONG CYP3A4 INHIBITORS/ELAGOLIX
- STRONG CYP3A4 INHIBITORS/ARIPIPRAZOLE LAUROXIL SUBMICRONIZED
- SELECTED PROTEASE INHIBITORS/SODIUM FUSIDATE
- STRONG AND MODERATE CYP3A4 INHIBITORS/TEZACAFTOR-IVACAFTOR
- STRONG CYP3A4 INHIBITORS/IBRUTINIB
- STRONG CYP3A4 INHIBITORS/ACALABRUTINIB
- STRONG CYP3A4 INHIBITORS/ABEMACICLIB
- STRONG CYP3A4 INHIBITORS/COPANLISIB
- STRONG CYP3A4 INHIBITORS/BRIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/DEFLAZACORT
- SAQUINAVIR/SELECTED IMMUNOSUPPRESSANTS; TEMSIROLIMUS
- STRONG CYP3A4 INHIBITORS/VENETOCLAX
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/CARIPRAZINE
- OATP1B1 INHIBITORS/ELUXADOLINE
- STRONG CYP3A4 INHIBITORS/TRASTUZUMAB EMTANSINE
- STRONG 3A4 INHIBITORS/ESZOPICLONE > 2 MG; ZOPICLONE > 5 MG
- STRONG CYP3A4 INHIBITORS/DACLATASVIR
- STRONG & MODERATE CYP3A4 INHIBITORS/ELIGLUSTAT
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/VORAPAXAR
- STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
- STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
- STRONG CYP3A4 INHIBITORS/MACITENTAN
- DUAL STRONG CYP3A4 INHIBITOR & P-GP INHIBITORS/RIOCIGUAT
- STRONG CYP3A4 INHIBITORS/REGORAFENIB
- STRONG CYP3A4 INHIBITORS; AMPRENAVIR;ATAZANAVIR/MIFEPRISTONE
- STRONG AND MODERATE CYP3A4 INHIBITORS/IVACAFTOR
- COBICISTAT; PROTEASE INHIBITORS/SALMETEROL
- PROTEASE INHIBITORS/BOSENTAN
- STRONG CYP3A4 INHIBITORS; DARUNAVIR/EVEROLIMUS
- SLT PROTEASE INHIBITORS/BARBITURATES;PHENOBARBITAL;PHENYTOIN
- SELECTED PROTEASE INHIBITORS/MARAVIROC
- LOPINAVIR; SAQUINAVIR; OMBITAS-PARITAP-RITONAVIR/DARUNAVIR
- STRONG CYP3A4 INHIBITORS/COLCHICINE
- SELECTED CYP3A4 INHIBITORS/SELECTED OPIOIDS
- SELECTED CYP3A4 INHIBITORS/SELECTED STEROIDS
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED PROTEASE INHIBITORS/LOPINAVIR
- SAQUINAVIR/POSSIBLE QT PROLONGING AGENTS
- SAQUINAVIR/PROTON PUMP INHIBITORS
- SELECTED PROTEASE INHIBITORS/NIRMATRELVIR-RITONAVIR
- POSSIBLE QT PROLONGING AGENTS/DEXMEDETOMIDINE SUBLINGUAL
- STRONG CYP3A4 INHIBITORS/VAMOROLONE
- STRONG AND MODERATE 3A4 INHIBITORS THAT PROLONG QT/ETRASIMOD
- OATP1B1-3 INHIBITORS/MOMELOTINIB
- SLT STRONG CYP3A4 INHIBIT/AMLODIPINE; LEVAMLODIPINE
- STRONG CYP3A4 INHIBITORS/ZURANOLONE
- STR CYP3A4 INHIB;ATAZAN;DARUNAV/SLT LONG-ACTING ARIPIPRAZOLE
- STRONG CYP3A4 INHIBITORS/BORTEZOMIB
- SELECT PROTEASE INHIBITORS; COBICISTAT/TADALAFIL (PAH)
- STRONG CYP3A4 INHIBITORS/VALBENAZINE (=< 40 MG)
- QT PROLONGING AGENTS/TUCIDINOSTAT
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (<=10.5 MG)
- SELECTED CYP3A4 INHIBITORS/MOMETASONE
- QT PROLONGING AGENTS/TRICLABENDAZOLE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GILTERITINIB
- STR 3A4 INHIBITORS THAT PROLONG QT/PANOBINOSTAT (<= 10 MG)
- STR 3A4 INHIB THAT PROL QT/TOLTERODINE (<=1 MG OR <=2 MG ER)
- STRONG CYP3A4 INHIBITORS/UPADACITINIB (<30 MG)
- SELECTED POSSIBLE QT PROLONGING AGENTS/INTRAVENOUS LEFAMULIN
- QT PROLONGING AGENTS/OZANIMOD
- QT PROLONGING AGENTS/PONESIMOD
- QT PROLONGING AGENTS/SIPONIMOD
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/MIDOSTAURIN
- STRONG CYP3A4 INHIBITORS/IBREXAFUNGERP
- QT PROLONGING AGENTS/GALANTAMINE
- STRONG CYP3A4 INHIBITORS/REPAGLINIDE
- PROTEASE INHIBITORS/SELECTED BENZODIAZEPINES
- POSSIBLE QT PROLONGING AGENTS/LEVOMEPROMAZINE
- STRONG OR MODERATE CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- STRONG CYP3A4 INHIBITORS/FOSTAMATINIB
- POSSIBLE QT PROLONGING AGENTS/OXALIPLATIN
- QT PROLONGING AGENTS/AMISULPRIDE
- STRONG CYP3A4 INHIBITORS/CANNABIDIOL-TETRAHYDROCANNABINOL
- SELECTED STRONG CYP3A4 INHIBITORS;PROTEASE INHIB/MEFLOQUINE
- STRONG CYP3A4 INHIBITORS/ZANUBRUTINIB
- DUAL P-GP AND STRONG CYP3A4 INHIBITORS/DAROLUTAMIDE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ILOPERIDONE
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/BREXPIPRAZOLE
- QT PROLONGING AGENTS/PITOLISANT
- POSSIBLE QT PROLONGING AGENTS/LOFEXIDINE
- POSSIBLE QT PROLONGING AGENTS/MACIMORELIN
- POSSIBLE QT PROLONGING AGENTS/INOTUZUMAB OZOGAMICIN
- POSSIBLE QT PROLONGING AGENTS/HYDROXYZINE
- SELECTED CYP3A4 INHIBITORS/BROMOCRIPTINE; CABERGOLINE
- SELECTED CYP3A4 INHIBITORS/FELODIPINE
- POSSIBLE QT PROLONGING AGENTS/OSIMERTINIB
- POSSIBLE QT PROLONGING AGENTS/LENVATINIB
- STRONG 3A4 INHIB/LEVOMILNACIPRAN(<=80MG);VILAZODONE(<=20MG)
- P-GLYCOPROTEIN (P-GP) INHIBITORS/AFATINIB
- QT PROLONGING AGENTS/FINGOLIMOD
- SELECTED PROTEASE INHIBITORS/ATORVASTATIN (<= 20 MG)
- POSSIBLE QT PROLONGING AGENTS/GADOFOSVESET
- SLT PROTEASE INHIB;COBICISTAT/SILDENAFIL (ED);TADALAFIL (ED)
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN(<=2.5 MG)
- SLT STRONG CYP3A4 INHIBIT/SELECTED CALCIUM CHANNEL BLOCKERS
- SELECTED PROTEASE INHIBITORS/ROSUVASTATIN
- QT PROLONGING AGENTS/POSACONAZOLE
- STRONG CYP3A4 INHIBITORS/BUSPIRONE
- QT PROLONGING AGENTS/NORFLOXACIN
- STRONG CYP3A4 INHIBITORS/ESZOPICLONE; ZOPICLONE; ZOLPIDEM
- SELECTED CYP3A4 INHIBITORS/ITRACONAZOLE; KETOCONAZOLE
- STRONG CYP3A4 INHIBITORS/CINACALCET
- SELECTED PROTEASE INHIBITORS/VARDENAFIL (<= 2.5 MG)
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/ARIPIPRAZOLE
- STRONG CYP3A4 INHIBITORS/SLT LOW STRENGTH ANTIMUSCARINICS
- STRONG & MOD 3A4 INHIB THAT PROLONG QT/CILOSTAZOL (<=50MG)
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.